DNA molecular scissors as new cancer chemotherapeutics
نویسندگان
چکیده
منابع مشابه
Molecular scissors under light control.
L ight plays a key role in the living world. It serves as a source of energy through photosynthesis, makes sight possible, and regulates circadian rhythms. During evolution, organisms from bacteria to higher mammals elaborate various mechanisms to sense and respond to light, which manipulates their behavior. The use of light as a trigger is particularly attractive as a means of controlling biol...
متن کاملPlasmonic scissors for molecular design.
Heterogeneous catalysts play an important role in surface catalytic reactions, but selective bond breaking and control of reaction products in catalytic processes remain significant challenges. High-vacuum tip-enhanced Raman spectroscopy (HV-TERS) is one of the best candidates to realize surface catalytic reactions. Herein, HV-TERS was employed in a new method to control dissociation by using h...
متن کاملThe potential of farnesyltransferase inhibitors as cancer chemotherapeutics.
Mutant ras oncogenes and alterations in the mitogenic signaling pathways that they regulate are associated with a wide variety of solid tumors and leukemias for which existing chemotherapeutics have limited utility. Of the possible approaches to inhibit Ras function, much attention has focused on a posttranslational modification, farnesylation, which is required for the subcellular localization...
متن کاملFarnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
The family of Ras proteins plays a central role in the regulation of cell growth and integration of regulatory signals which can govern the cell cycle and proliferation. Mutant m s genes (derived from murine sarcoma viruses) were among the first oncogenes described for their ability to transform cells to a cancerous phenotype [l]. Mutations in one of the three genes (H-, Nand K-rus) encoding Ra...
متن کاملAntibody–drug conjugates as novel anti-cancer chemotherapeutics
Over the past couple of decades, antibody-drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and deliver a highly potent cytotoxic agent. The synergistic combination of mAbs conjugated to small...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Research Outreach
سال: 2022
ISSN: ['2517-701X', '2517-7028']
DOI: https://doi.org/10.32907/ro-129-2533005901